These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30017552)

  • 1. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Rothwell PM; Cook NR; Gaziano JM; Price JF; Belch JFF; Roncaglioni MC; Morimoto T; Mehta Z
    Lancet; 2018 Aug; 392(10145):387-399. PubMed ID: 30017552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
    Benziger CP; Stebbins A; Wruck LM; Effron MB; Marquis-Gravel G; Farrehi PM; Girotra S; Gupta K; Kripalani S; Munoz D; Polonsky TS; Sharlow A; Whittle J; Harrington RA; Rothman RL; Hernandez AF; Jones WS
    JAMA Cardiol; 2024 Sep; 9(9):808-816. PubMed ID: 38985488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.
    Joseph P; Roshandel G; Gao P; Pais P; Lonn E; Xavier D; Avezum A; Zhu J; Liu L; Sliwa K; Gamra H; Bangdiwala SI; Teo K; Diaz R; Dans A; Lopez-Jaramillo P; Prabhakaran D; Castellano JM; Fuster V; Rodgers A; Huffman MD; Bosch J; Dagenais GR; Malekzadeh R; Yusuf S;
    Lancet; 2021 Sep; 398(10306):1133-1146. PubMed ID: 34469765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
    Rothwell PM; Price JF; Fowkes FG; Zanchetti A; Roncaglioni MC; Tognoni G; Lee R; Belch JF; Wilson M; Mehta Z; Meade TW
    Lancet; 2012 Apr; 379(9826):1602-12. PubMed ID: 22440946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
    Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
    ; Baigent C; Blackwell L; Collins R; Emberson J; Godwin J; Peto R; Buring J; Hennekens C; Kearney P; Meade T; Patrono C; Roncaglioni MC; Zanchetti A
    Lancet; 2009 May; 373(9678):1849-60. PubMed ID: 19482214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
    Rothwell PM; Wilson M; Elwin CE; Norrving B; Algra A; Warlow CP; Meade TW
    Lancet; 2010 Nov; 376(9754):1741-50. PubMed ID: 20970847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low-dose aspirin on colorectal cancer prevention and gastrointestinal bleeding according to bodyweight and body mass index: Analysis of UK primary care data.
    Cea Soriano L; Vora P; Soriano-Gabarró M; García Rodríguez LA
    Int J Cardiol; 2019 Dec; 297():135-139. PubMed ID: 31515060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
    Bhatt DL; Eikelboom JW; Connolly SJ; Steg PG; Anand SS; Verma S; Branch KRH; Probstfield J; Bosch J; Shestakovska O; Szarek M; Maggioni AP; Widimský P; Avezum A; Diaz R; Lewis BS; Berkowitz SD; Fox KAA; Ryden L; Yusuf S;
    Circulation; 2020 Jun; 141(23):1841-1854. PubMed ID: 32223318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Li L; Geraghty OC; Mehta Z; Rothwell PM;
    Lancet; 2017 Jul; 390(10093):490-499. PubMed ID: 28622955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
    Roshandel G; Khoshnia M; Poustchi H; Hemming K; Kamangar F; Gharavi A; Ostovaneh MR; Nateghi A; Majed M; Navabakhsh B; Merat S; Pourshams A; Nalini M; Malekzadeh F; Sadeghi M; Mohammadifard N; Sarrafzadegan N; Naemi-Tabiei M; Fazel A; Brennan P; Etemadi A; Boffetta P; Thomas N; Marshall T; Cheng KK; Malekzadeh R
    Lancet; 2019 Aug; 394(10199):672-683. PubMed ID: 31448738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.